IMMUCELL CORP /DE/ Quarterly Depreciation in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Immucell Corp /De/ quarterly/annual Depreciation history and growth rate from Q1 2011 to Q3 2024.
  • Immucell Corp /De/ Depreciation for the quarter ending September 30, 2024 was $670K, a 3.64% decline year-over-year.
  • Immucell Corp /De/ Depreciation for the twelve months ending September 30, 2024 was $2.67M, a 1.59% increase year-over-year.
  • Immucell Corp /De/ annual Depreciation for 2023 was $2.7M, a 9.29% increase from 2022.
  • Immucell Corp /De/ annual Depreciation for 2022 was $2.47M, a 1.08% increase from 2021.
  • Immucell Corp /De/ annual Depreciation for 2021 was $2.44M, a 4.89% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.67M $670K -$25.3K -3.64% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $2.69M $666K -$13.8K -2.04% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $2.71M $662K +$10.3K +1.59% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.7M $670K +$70.6K +11.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $2.63M $696K +$68.1K +10.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $2.56M $680K +$55.4K +8.87% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2.5M $652K +$35.3K +5.72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $2.47M $599K +$3.05K +0.51% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $2.47M $628K +$14.2K +2.31% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.45M $625K +$7.08K +1.15% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.44M $617K +$2.15K +0.35% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.44M $596K -$12.4K -2.03% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $2.45M $613K +$17.4K +2.92% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 $2.44M $618K +$49.3K +8.67% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-21
Q1 2021 $2.39M $615K +$59.6K +10.7% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-11-21
Q4 2020 $2.33M $609K +$51.5K +9.25% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $2.28M $596K +$33.3K +5.92% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $2.24M $568K +$3.74K +0.66% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $2.24M $555K -$8.68K -1.54% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $2.25M $557K -$5.92K -1.05% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 $2.25M $563K +$185K +48.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $2.07M $565K +$284K +101% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.79M $564K +$284K +101% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $1.5M $563K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $378K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $281K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $280K +$66.4K +31.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q1 2017 $213K +$50.9K +31.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2016 $163K +$46.9K +40.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q1 2015 $116K +$3.3K +2.94% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q1 2014 $112K +$15.2K +15.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q1 2013 $97.1K -$6.09K -5.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q1 2012 $103K -$1.94K -1.85% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q1 2011 $105K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.